We hypothesize that blockade of IRE1 signaling will preserve the oncologic efficacy of chemotherapy while preventing chemotherapy‐related cardiac toxicity in TNBC preclinical breast cancer models in the context of obesity. Here, ERN1 is linked to obesity disorder.